Trial intelligence / Profile preview

Triamcinolone Acetonide DuraPeel in Hand Dermatitis

NCT00890968Phase 2Completed

Sponsor
ZARS Pharmaceuticals
Start
Apr 2009
Primary completion
Jun 2009
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of triamcinolone acetonide in hand dermatitis, sponsored by ZARS Pharmaceuticals. Started Apr 2009; status: completed.

02

Drugs

triamcinolone acetonide
03

Conditions

hand dermatitis

Beyond the preview

Go deeper on NCT00890968.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00890968.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call